VIVO Cannabis Announces Fourth Quarter 2022 Results
Net revenue for Q4 2022 was $7.1 million, a 15% increase from prior quarter.Net revenue for 2022 was $25.4 million, a 2% increase compared to 2021.Net losses have decreased by 21.2 million in 2022, a 30% decrease from the prior year.The Company signed a definitive agreement with MediPharm Labs Inc. whereby MediPharm has agreed to acquire VIVO Cannabis Inc. in an all-equity business combination transaction. Shareholders of the Company held a special meeting during which the Arrangement...
2023-03-28 7:27 AM EDT
VIVO Cannabis Obtains Final Court Order Approving Its Plan of Arrangement with MediPharm
Toronto, Ontario--(Newsfile Corp. - March 24, 2023) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQB: VVCIF) ("VIVO") is pleased to announce that it has obtained a final court order (the "Final Order") from the Ontario Superior Court of Justice (Commercial List) approving the previously announced plan of arrangement (the "Arrangement") with MediPharm Labs Corp. ("MediPharm") under the Canada Business Corporations Act. As previously announced, the Arrangement was approved at the special meeting of the...
2023-03-24 3:15 AM EDT
VIVO Cannabis Announces Approval of Proposed Arrangement at Special Meeting of Shareholders
Toronto, Ontario--(Newsfile Corp. - March 21, 2023) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQB: VVCIF) ("VIVO") is pleased to announce that, at the special meeting of the shareholders of VIVO (the "Shareholders") held today (the "Meeting"), the Shareholders approved (i) a special resolution (the "Arrangement Resolution") authorizing a plan of arrangement under section 192 of the Canada Business Corporations Act (the "Arrangement"), previously announced on December 22, 2022, pursuant to which...
2023-03-21 10:26 PM EDT
MediPharm Labs Corp. to Acquire VIVO Cannabis Inc.
Two global leaders in the medical wellness cannabis industry expected to combine complementary strengths of diversified revenue in multiple markets and channels to create a pro-forma Combined Company with over $50M in annualized revenue, based on Q3 2022.(1)(2)(3)(4)Pro-forma Combined Company is expected to have positive EBITDA(5) synergies of between $7M to $9M on an annualized basis within 12 months closing of the Transaction.(1)(2)(3)(4)Transaction is expected to accelerate MediPharm Labs'...
2022-12-22 8:45 AM EST
VIVO Cannabis Announces Third Quarter 2022 Results
Other income as part of a dismissed arbitration matterToronto, Ontario--(Newsfile Corp. - November 14, 2022) - VIVO Cannabis...
2022-11-14 10:55 PM EST
VIVO Cannabis Announces Third Supplemental Debenture Indenture
Toronto, Ontario--(Newsfile Corp. - October 3, 2022) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company") is pleased to announce that, further to the Company's news release of September 19, 2022, the Company has entered into a third supplemental debenture indenture dated September 29, 2022 (the "Supplemental Indenture") with TSX Trust Company ("TSXT") in respect of its outstanding unsecured convertible debentures in the aggregate principal amount of $5,546,808...
2022-10-03 7:00 AM EDT
VIVO Cannabis Announces Agreement to Amend Outstanding Debentures
Toronto, Ontario--(Newsfile Corp. - September 19, 2022) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company") has entered into an agreement dated September 15, 2022 with the majority beneficial owner of its outstanding unsecured convertible debentures dated February 28, 2018 in the aggregate principal amount of $5,546,808 (collectively, the "Debentures") to amend the terms of the Debentures (the "Amendments")."We are pleased to have reached an agreement which mitigates our...
2022-09-19 8:00 AM EDT
VIVO Cannabis Announces Second Quarter 2022 Results
ONToronto, Ontario--(News
2022-08-15 6:26 PM EDT
VIVO Cannabis Announces Canna Farms Granted Research Licence by Health Canada
Toronto, Ontario--(Newsfile Corp. - July 22, 2022) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of medical cannabis products and patient services, and holder of licences under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms"), ABcann Medicinals Inc., today announced that Canna Farms has received a Research Licence from Health Canada allowing it to possess cannabis for the purpose of research. The...
2022-07-22 7:30 AM EDT
VIVO Cannabis Announces Results of 2022 AGM and Election of New Directors
Toronto, Ontario--(Newsfile Corp. - July 2, 2022) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQB: VVCIF) ("VIVO" or the "Company"), a leading provider of premium cannabis products and services, is pleased to announce the results of its annual general and special meeting of shareholders held today (the "Meeting"). As announced this morning, at the Meeting, shareholders approved fixing the number of directors at five, and the election of Ray Laflamme, Glen Huber, Shai Altman, Eric Shipman and Holly...
2022-07-02 12:16 AM EDT
VIVO Cannabis Announces Publication of Medical Cannabis Clinical Research Study in Psychiatric Research: Anxiety & Depression Outcomes in Medical Cannabis Patients
Toronto, Ontario--(Newsfile Corp. - June 3, 2022) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of medical cannabis products and patient services, and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms"), ABcann Medicinals Inc., today announced results from its first study investigating how medical cannabis impacts anxiety and depression outcomes. The publication, entitled "Medical...
2022-06-03 7:30 AM EDT
VIVO Cannabis Announces First Quarter 2022 Results
Psychiatric ResearchToronto, Ontario--(Newsfile Corp. - May 16, 2022) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the...
2022-05-16 10:00 PM EDT
VIVO Cannabis Announces Fourth Quarter 2021 Results
Net revenue for Q4 2021 was $6.9 million; Net revenue for 2021 was $25 million.In February 2021, closed a $7.2 million equity raise to help fund VIVO's growth In July 2021, the Company elected a new Board of Directors, announced the appointment of Ray Laflamme as CEO and Chairman of the Board and later welcomed the Former President of McCain Foods Canada and CEO of Zenabis Global, and Former CFO of Cronos Group, to the Board of Directors. In...
2022-03-31 7:57 AM EDT
VIVO Cannabis(TM) Adds Assuage Suppositories to Online Medical Marketplace
Toronto, Ontario--(Newsfile Corp. - February 11, 2022) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of medical cannabis products and patient services, and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms") and ABcann Medicinals Inc., today announced a partnership with Cicatrix Labs Ltd. ("Cicatrix Labs") to offer Assuage™ vaginal and rectal suppositories on VIVO's Canna Farms...
2022-02-11 7:00 AM EST
VIVO Cannabis(TM) Announces Appointment of Former President and CEO of Zenabis Global, and Former CFO of Cronos Group, to the Board
Toronto, Ontario--(Newsfile Corp. - December 21, 2021) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company") is pleased to announce the appointment of Shai Altman and Glen Huber to the board of directors of the Company (the "Board"), effective immediately."I am very pleased to welcome Mr. Altman and Mr. Huber to the Board of Directors," said Ray Laflamme, Chairman of the Board and Chief Executive Officer of VIVO. "Both Mr. Huber and Mr. Altman have strong leadership,...
2021-12-21 7:30 AM EST
VIVO Cannabis(TM) Announces Launch of Beacon Medical(TM) High-Dose CBD Oil and Pediatric Compassionate Care Program
Toronto, Ontario--(Newsfile Corp. - November 23, 2021) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of medical cannabis products and patient services, and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms") and ABcann Medicinals Inc., today announced the launch of its newest medical cannabis product formulation: high-dose cannabidiol (CBD) oil under its Beacon Medical™...
2021-11-23 5:30 PM EST
VIVO Cannabis(TM) Supports Patients and Hope Community During BC Flooding
Toronto, Ontario--(Newsfile Corp. - November 19, 2021) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of medical cannabis products and patient services, and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms") and ABcann Medicinals Inc., today provided an update on the recent flooding situation affecting Southern British Columbia.VIVO's facility in Hope, BC is at the epicentre of the...
2021-11-19 7:32 PM EST
VIVO Cannabis(TM) Announces Third Quarter 2021 Results
Net revenue $6.2 millionNet loss reduced to $1.1 million; EBITDA loss reduced to $2.1 millionFirst shipment to Germany completed; Australia sales $2.2 millionToronto, Ontario--(Newsfile Corp. - November 15, 2021) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company") today released its third quarter 2021 financial and operating results.Management CommentaryAt the start of the third quarter of 2021, significant changes were made to focus VIVO's strategy on the medical...
2021-11-15 9:44 PM EST
VIVO Cannabis(TM) Announces Launch of New Lumina(TM) Products
Toronto, Ontario--(Newsfile Corp. - November 3, 2021) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of medical cannabis products and patient services, and holder of licences under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms") and ABcann Medicinals Inc., today announced the launch of new products under its Lumina™ health and wellness brand.Lumina™ Ultralight 0:50 is a high cannabidiol (CBD)...
2021-11-03 5:00 PM EDT
VIVO Cannabis(TM) Completes First Shipment of EU-GMP Medical Grade Cannabis to Beacon Medical Germany GmbH
Toronto, Ontario--(Newsfile Corp. - October 21, 2021) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading medical cannabis company and holder of licenses under the Cannabis Act through its wholly owned subsidiaries, Canna Farms Limited ("Canna Farms") and ABcann Medicinals Inc. ("ABcann Medicinals"), today announced that its EU-GMP licensed subsidiary ABcann Medicinals has successfully completed its first shipment of EU-GMP certified Canadian dried flower...
2021-10-21 7:30 AM EDT